Search: onr:"swepub:oai:gup.ub.gu.se/307031" >
Concordance of csf ...
Concordance of csf measures of alzheimer’s pathology with amyloid pet status in a preclinical cohort: A comparison of lumipulse and established immunoassays
-
Keshavan, A. (author)
-
Wellington, H. (author)
-
Chen, Z. (author)
-
show more...
-
Khatun, A. (author)
-
Chapman, M. (author)
-
Hart, M. (author)
-
Cash, D. M. (author)
-
Coath, W. (author)
-
Parker, T. D. (author)
-
Buchanan, S. M. (author)
-
Keuss, S. E. (author)
-
Harris, M. J. (author)
-
Murray-Smith, H. (author)
-
Heslegrave, A. (author)
-
Fox, N. C. (author)
-
- Zetterberg, Henrik, 1973 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
-
Schott, J. M. (author)
-
show less...
-
(creator_code:org_t)
- 2021-02-06
- 2021
- English.
-
In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. - : Wiley. - 2352-8729. ; 13:1
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- INTRODUCTION: We assessed the concordance of cerebrospinal fluid (CSF) amyloid beta (Aβ) and tau measured on the fully automated Lumipulse platform with presymptomatic Alzheimer’s disease (AD) pathology on amyloid positron emission tomography (PET). METHODS: In 72 individuals from the Insight 46 study, CSF Aβ40, Aβ42, total tau (t-tau), and phosphorylated tau at site 181 (p-tau181) were measured using Lumipulse, INNOTEST, and Meso Scale Discovery (MSD) assays and inter-platform Pearson correlations derived. Lumipulse Aβ42 measures were adjusted to incorporate standardization to certified reference materials. Logistic regressions and receiver operating characteristics analysis generated CSF cut-points optimizing concordance with18F florbetapir amyloid PET status (n = 63). RESULTS: Measurements of CSF Aβ, p-tau181, and their ratios correlated well across platforms (r 0.84 to 0.94, P < .0001); those of t-tau and t-tau/Aβ42 correlated moderately (r 0.57 to 0.79, P < .0001). The best concordance with amyloid PET (100% sensitivity and 94% specificity) was afforded by cut-points of 0.075 for Lumipulse Aβ42/Aβ40, 0.087 for MSD Aβ42/Aβ40 and 17.3 for Lumipulse Aβ42/p-tau181. DISCUSSION: The Lumipulse platform provides comparable sensitivity and specificity to established CSF immunoassays in identifying pre-symptomatic AD pathology. © 2020 The Authors.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Keyword
- Amyloid
- Cerebrospinal fluid
- Lumipulse
- Positron emission tomography
- Tau
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Keshavan, A.
-
Wellington, H.
-
Chen, Z.
-
Khatun, A.
-
Chapman, M.
-
Hart, M.
-
show more...
-
Cash, D. M.
-
Coath, W.
-
Parker, T. D.
-
Buchanan, S. M.
-
Keuss, S. E.
-
Harris, M. J.
-
Murray-Smith, H.
-
Heslegrave, A.
-
Fox, N. C.
-
Zetterberg, Henr ...
-
Schott, J. M.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Neurosciences
- Articles in the publication
-
Alzheimer's and ...
- By the university
-
University of Gothenburg